Bristol-Myers Squibb Rights
CELG.RT
27 hedge funds and large institutions have $291K invested in Bristol-Myers Squibb Rights in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
577% more capital inflows, than outflows
Capital inflows: $80.1K | Capital outflows: $11.8K
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
4% less funds holding
Funds holding: 28 → 27 (-1)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Transcend Capital Advisors
Madison,
New Jersey
|
+$65.8K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.19K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$6.98K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$101 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Selway Asset Management
|
-$6.88K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.21K |
| 3 |
Morgan Stanley
New York
|
-$629 |
| 4 |
Quadrant Capital Group
Cincinnati,
Ohio
|
-$120 |
CELG.RT Hedge Fund Activity: Q1 2020 in Review
27 of the 4,549 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q1 2020, worth a combined $291K — up 24% from $234K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CELG.RT positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Transcend Capital Advisors, opening a new position worth an estimated $65.8K. The largest seller was Selway Asset Management, cutting an estimated $6.88K.
- 27 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q1 2020, down from 28 in Q4 2019.
- Funds reported $291K of Bristol-Myers Squibb Rights stock for Q1 2020, up 24% quarter-over-quarter.
- 4 funds opened new Bristol-Myers Squibb Rights positions in Q1 2020 and 3 closed out, a net change of +1 holder.
- The largest Bristol-Myers Squibb Rights buyer in Q1 2020 was Transcend Capital Advisors, an estimated $65.8K added.
- The largest Bristol-Myers Squibb Rights seller in Q1 2020 was Selway Asset Management, an estimated $6.88K sold.
Based on aggregated 13F filings for Q1 2020.